Menu

Asheville-based start-up using AI to control glucose in the critical care space

An Asheville-based start-up that is using artificial intelligence (AI) to control glucose in the critical care space has raised $200,000 in debt, according to this article in WRAL TechWire. The company – Ideal Medical Technologies – is developing an AI-based artificial pancreas system called FUSION. It uses software that adjusts the doses of intravenous insulin/glucose infusing into the patients on a five- to 10-minute basis.

Stay connected with us on Twitter and LinkedIn. Article ideas and other suggestions should be sent to tballard@pyapc.com. Include the name and contact information (phone and email) for follow-up.